Figure 1.
Relative expression of SLC11A1 mRNA in splenic aspirates from VL patients (A) before (Day 0), and (B) after (Day 30), antileishmanial treatment. Data are shown according to genotype (3/3, 2/3, 2/2) at the SLC11A1 GTn promoter repeat polymorphism. Values represent mean ± SEM. Paired Student's T test showed no significant differences in expression of SLC11A1 when D0 values were compared to D30 valules for each genotype. No differences between genotypes were observed at either D0 or D30 as deteremined by one way ANOVA.